Under-reporting of drug-related death in official statistics is a critical public health issue. A more detailed knowledge amongst statistical coders of the complex causality, circumstances and toxicology of drug-related death is crucial if official statistics are to become more accurate.
The accurate reporting of drug-related death is of critical public health importance. There is, however, good reason to believe that the official statistics provide substantial underestimates. In their study Stam et al. [1] draw attention to this crucial issue. The authors compared their close examination of the coronial records of heroin-related death with official figures covering the same period. They found a 32% under-reporting in the official figures, which is clearly of major concern.
Why was this the case? It is not the result of a conspiracy, but appears to be due to an inadequate understanding of the nature of heroin-related death by those collecting official figures. Two major problems were identified. First, it is well known that most heroin-related deaths are due to multiple drug toxicity (typically involving alcohol and/or benzodiazepines as well as heroin). The cause of death in such cases is frequently given in coronial records as 'multiple drug toxicity', and these cases appear to be systematically missed by official coders. Secondly, the complex metabolism of heroin appears to cause coding errors. Heroin (diacetylmorphine) is a prodrug and is never detected in toxicology. After administration heroin is rapidly metabolized to 6-monoacetyl morphine (6MAM), and then to morphine. The presence of 6MAM is frequently used as a biomarker for a heroin overdose death. This will, however, only pick up cases with survival times of less than 30 minutes, which represent the minority of heroin overdose deaths [2] . Moreover, coronial records of heroin overdose cases frequently attribute 'morphine toxicity' as the cause of death, reflecting the metabolism of heroin. It would appear that such cases are often missed by those coding official statistics, attributing them to morphine consumption rather than heroin. There is no reason to believe this is a local Australian problem, as the issues raised by the authors are applicable globally.
The implications of this study extend beyond the opioids. Psychostimulants provide an excellent example of under-reporting, as the number of official psychostimulant-related deaths is absurdly low when compared to coronial records. This is due to the fact that such deaths are predominantly due to causes other than acute toxicity, such as psychostimulant-induced cardiovascular disease, stroke, traumatic accident and suicide [2] [3] [4] . Such cases are likely to be missed in official statistics, even though these deaths are attributable to psychostimulant use. As with opioids, there appears to be problems with awarness of the mechanisms of death. A similar situation is likely to apply to cannabis, where there are no documented deaths due to acute cannabis toxicity and the major contributor to mortality is traumatic accident [5] .
How can this situation be improved, and the burden of disease contributed by drugs be more accurately quantified? Official coders do their job to the best of their ability within the resources available. The Stam et al. study does, however, indicate specific areas where case detection could be improved. A more detailed knowledge amongst statistical coders of the causality, circumstances and toxicology of drug-related death is crucial if official statistics are to become more accurate. More studies that specifically examine coronial records are also in order. It is surprising how few such studies are conducted, and how many studies limit themselves to an analysis of official statistics. The study by Stam et al. shines a light on a major public health problem. I commend this important work to all who have an interest in the accurate reporting of drug-related death.
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